Importantly, this finding is clinically relevant, as levels of SMARCA4 mRNA were significantly elevated in the metastatic NB cases, namely the high-risk, recurrent, or progressed patient NB, compared to the other patient NB cases (Appendix Fig. S3H). The gene discussed is SMARCA4; the disease is neuroblastoma.